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ABSTRACT
Objective: The aim of this study was to assess radiographically the effect of photodynamic therapy (PDT) as an adjunctive treatment to scaling and root planing (SRP) on induced 
periodontitis in dexamethasone-induced immunosuppressed rats. Material and Methods: The 
 !"# $%&'()(&*"+"*(*&"!,-&.&/)-01%2&34&/)-01&5!67892&% $"!(&,)( ,#(!,:&4&/)-01&5!67892&
dexamethasone treatment. In both ND and D groups, periodontal disease was induced by 
,;(&1$ <(#(!,&-=& &$"/ ,0)(&"!&,;(&$(=,&>)%,&# !*"?0$ )&#-$ )@&A=,()&B&* C%D&$"/ ,0)(&' %&
removed and all animals received SRP, being divided according to the following treatments: 
SRP: saline and PDT: phenothiazinium dye (TBO) plus laser irradiation. Ten animals per 
treatment were killed at 7, 15 and 30 days. The distance between the cementoenamel 
junction and the height of the alveolar bone crest in the mesial surface of the mandibular left 
>)%,&#-$ )%&' %&*(,()#"!(*&"!&#"$$"#(,()%&"!&( <;&) *"-/) 1;@&E;(&) *"-/) 1;"<&+ $0(%&'()(&
analyzed statistically by ANOVA and Tukey’s test at a p value <0.05. Results: Intragroup 
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less bone loss in the animals treated with PDT in all experimental periods compared to those 
submitted to SRP. Intergroup radiographic analysis (ND and D groups) demonstrated that 
there was greater bone loss in the ND group treated with SRP compared to the D group 
treated with PDT at 7 and 30 days. Conclusion: PDT was an effective adjunctive treatment 
to SRP on induced periodontitis in dexamethasone-induced immunosuppressed rats.
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INTRODUCTION
Periodontal disease is the result of the collapse 
of tooth supporting structures by the local action 
of periodontopathogenic microorganisms24. These 
microorganisms release substances that strictly 
injury periodontal tissues in addition to inducing 
,"%%0(&*(%,)0<,"-!&?C&,;(&;-%,F%&"!G ## ,-)C& !*&
immunologic responses. Systemic factors such 
as diabetes, smoking, alcohol consumption22 and 
stress have been found to be associated with 
severe and/or rapidly progressive periodontitis. 
Furthermore, some medications have an impact 
on the periodontium and its response to bacterial 
plaque20.
In the last decades, organ transplant has become 
an accepted treatment for a range of acquired and 
congenital disorders. Corticoids are commonly used 
to treat many different diseases because of their 
 !,"H"!G ## ,-)C&(==(<,& !*&"##0!-%011)(%% !,&
properties. Glucocorticoids link to receptors inside 
the cell and cause redistribution of the lymphocytes. 
They also reduce T-cell proliferations, with a 
decrease in interleukin-2, and also downregulate 
interleukin-1 and interleukin-6, thereby attenuating 
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Prolonged therapy with corticoids may favor 
osteoporosis, which is now regarded as a risk factor 
for periodontal disease20. The systemic use of drugs 
%0<;& %&!-!H%,()-"* $& !,""!G ## ,-)C&%0?%, !<(%&
and their possible effects on periodontal disease 
have been studied6. The use of corticoids can 
provoke from gingival ulceration up to downward 
migration of the epithelium, attachment loss 
 !*& ,) !%(1, $& >?()& *"%)01,"-!6. In addition, the 
systemic use of high doses of glucocorticoids 
leads to fibroblast activity inhibition, collagen 
and connective tissue loss, with decreasing re-
reepithelization and angiogenesis14, reduction 
of number and activity of the osteoblasts, and 
increasing osteoclast function18. However, clinical 
studies are somewhat equivocal with respect to the 
effect of systemic glucocorticoids on periodontal 
tissues13.
Periodontal treatment is based on pathogenic 
microbiota reduction by scaling and root planing. 
However, mechanical therapy used alone can fail 
to eliminate pathogenic bacteria that are lodged 
deeply in the soft tissue, and also in inaccessible 
areas to the periodontal instruments, such as the 
furcation area and root depression1. 
Systemic disease and adverse drug reactions 
address strategic challenges to the elaboration of 
a conventional periodontal treatment plan, leading 
to the use of complementary therapies in order 
to compensate for the intrinsic alterations related 
to periodontal repair process. Because of these 
limitations, adjuvant methods that provide for the 
elimination of periodontal pathogens have called 
the attention of many researchers, who consider 
antibiotic and antiseptic use as effective in the 
periodontal treatment15. On the other hand, there 
are also uncountable studies demonstrating the 
selection and resistance of bacteria provided by the 
overuse of antimicrobial drugs in the periodontal 
therapeutics25,28. 
Recently, some in vitro7,17,30 and in vivo2,4 
studies have shown satisfactory results with the 
use of photodynamic therapy (PDT). However, the 
introduction of PDT as an adjuvant periodontal 
treatment in immunosuppression conditions has 
not yet been reported in the literature.
This therapy consists in the association of a 
photosensitizer with an intense light source, both 
aiming to promote cellular death. The photodynamic 
activity of photosensitizers is based on photo-
oxidative reactions that provide biochemical and 
morphological alterations in target cells. When the 
photosensitizer drug molecule absorbs light from a 
resonant energy, it is turned into a single exciting 
state. Depending on its molecular structure and 
environment, the molecule may then lose its energy 
by electronic or physical process, thus returning to 
the ground state, or it may undergo a transition to 
the triplet exciting state (unpaired electron spins). 
At this stage, the molecule may once more undergo 
electronic decay back to the ground state, it may 
either undergo redox reaction with its environment, 
or its excitatory energy may be transferred to 
molecular oxygen (also a molecular triplet-state) 
leading to the formation of the labile singlet oxygen 
(type-II reaction). This type of oxygen reactive 
species (ROS) is responsible for irreversible damage 
on bacterial cytoplasm membrane, including protein 
#-*">< ,"-!D& )(%1") ,-)C& <; "!& ?)( I*-'!&  !*&
nucleic acid alterations27.
The major advantages of PDT are being a 
%1(<"><&,;() 1C&=-)&, )/(,&<($$%D&1)(%(!,"!/&!-&%"*(&
effects, initiating its activity only when exposed to 
light, and supporting no resistant bacteria species 
selection10, which is found to be rather common 
with the indiscriminate use of antibiotics25. 
In this context, PDT may be an alternative 
adjuvant method for nonsurgical periodontal 
treatment under immunosuppressant conditions. 
Considering that prolonged use of corticoids is 
associated with the reduction of number and activity 
of the osteoblasts, and the increase of osteoclastic 
function18, the aim of the present study was to 
<-#1 )(& ,;(& (=>< <C& -=& J4E& 1$0%& <-!+(!,"-! $&
mechanical therapy to scaling and root planing 
alone on alveolar bone loss in furcation areas of 
experimental periodontitis induced in rats either 
inhibited or not by dexamethasone. 
MATERIALS AND METHODS
This study was conducted on 120 adult male 
Wistar rats (120 to 140 g). The animals were kept 
in plastic cages with access to food and water ad 
libitum. Prior to the surgical procedures, all animals 
were allowed to acclimatize to the laboratory 
environment for a period of 5 days. All protocols 
described below were approved by the Institutional 
Review Board of Araçatuba Dental School, São Paulo 
State University, Araçatuba, SP, Brazil (Protocol 
no. 22/06).
 !"#$%&'()(*+!%+(,)$-!,+,.,/
Animals were then divided into 2 groups: D 
/)-01&5!6789D&';"<;&)(<("+(*&"!K(<,"-!%&-=&.&#/L
kg body weight15 of dexamethasone (DECADRON® 
2 mg, Prodome, Aché Pharmaceutical Laboratories 
MAD&N #1"! %D&MJD&O) P"$9:& !*&34&/)-01&5!6789D&
which received injections of 2 mg/kg body weight14 
of saline. The subcutaneous injections were 
initiated 24 h before the experimental induction of 
periodontal disease and maintained every 3 days6, 
during all the study period. 
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General anesthesia was obtained by association 
of ketamine (0.4 mL/kg) and xylazine (0.2 mL/kg) 
+" &"!,) #0%<0$ )&"!K(<,"-!@&Q!(&# !*"?0$ )&$(=,&>)%,&
molar of each animal in the ND and D groups was 
selected to receive a submarginal cotton ligature 
in order to induce experimental periodontitis12,19. 
After 7 days of periodontal disease induction, the 
ligature was removed from all animals of both 
groups. The left molars were then submitted to 
scaling and root planning (SRP) with Mini Five 13-
14 curettes (Hu-Friedy Co. Inc., Chicago, IL, USA) 
through 10 distal-mesial traction movements in 
both buccal and lingual aspects of the teeth. The 
furcation and interproximal areas were scaled 
with the same curettes through cervical-occlusal 
traction movements. Scaling and root planing was 
performed by the same experienced operator. The 
animals of each group (ND and D) were randomly 
assigned to one of the two treatments proposed 
(30 animals/treatment): SRP: the mandibular left 
molars were submitted to SRP and irrigation with 1 
mL of saline; and PDT: the mandibular left molars 
were submitted to SRP and irrigation with 1 mL 
of phenothiazinium dye (TBO - Toluidine Blue-O; 
Sigma Chemical Co., St. Louis, MO, USA) (100 µg/
mL) solution, followed by application of a low-level 
laser (LLL) source. Saline and TBO were slowly 
poured into the periodontal pocket with a syringe 
(1 mL) and an insulin needle (13 mm x 0.45 mm) 
(Becton Dickinson Ind. Ltd, Curitiba, PR, Brazil) 
without bevel.
The LLL source used in this study was gallium-
aluminum-arsenide (GaAlAs) (GaAlAs; Laser Bio 
Wave LLLT; Kondortech Equipment, São Carlos, SP, 
Brazil) with wavelength of 660 nm and spot size of 
0.07 cm2. After 1 min of TBO application, the LLL 
was applied in 3 equidistant points at each buccal 
 !*&$"!/0 $& %1(<,&-=&,;(&>)%,&# !*"?0$ )&#-$ )&"!&
contact with the tissue. The laser was delivered 
during 133 s per point, with power of 0.03 W, 
power density of 0.428 W/cm2 and energy of 4 J/
point (57.14 J/cm2/point). The area received a total 
energy of 24 J. 
01-2!('2)+%/$-2!(,&*
Ten animals of each group and treatment were 
killed at 7, 15 and 30 days after the periodontal 
disease treatment by administration of a lethal dose 
of thiopental (150 mg/kg) (Cristália Ltd, Itapira, SP, 
O) P"$9@&E;(&K '%&'()(&)(#-+(*& !*&>R(*&"!&S8T&
neutral formalin for 48 h.
 
Radiographic analysis
Rat left hemi-mandibles were removed to 
determine the level of bone loss. Standardized 
radiographs were obtained with the use of digital 
radiographic images provided by the Digora 
computerized imaging system (Soredex, Orion 
Corporation, Helsinki, Finland), which uses a 
%(!%-)&"!%,( *&-=& !&RH) C&>$#@&U$(<,)-!"<&%(!%-)%&
were exposed to 70 kV and 8 mA with exposure 
,"#(&-=&8@V&%(<-!*%@&E;(&%-0)<(H,-H>$#&*"%, !<(&
was 50 cm. The distance between the cementum-
enamel junction and the height of alveolar bone 
was determined for the mesial root surface of 
# !*"?0$ )& $(=,&>)%,&#-$ )%2. Millimeters of bone 
loss for each radiograph were measured three times 
in a blind fashion by the same examiner.
3)+!%21%'()2!$!2-!,&".(4(/(+5
Before the radiographic analysis was performed, 
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                 ND group- non-dexamethasone (saline)
Groups
Periods Initial periods 7 days 15 days 30 days
Treatments
SRP  (n=30) 245.85 ± 4.18 * 262.28 ± 2.05  *&† 282.85 ± 1.46  *&† 306.00 ± 0.81  *&†
PDT (n=30) 247.28 ± 5.31 * 261.42 ± 1.61 *&† 284.14 ± 2.03 *&† 307.85 ± 1.95*&†
N 60 20 20 20
         D group – dexamethasone
Groups
Periods Initial periods 7 days 15 days 30 days
Treatments
SRP (n=30) 246.85 ± 5.6 * 218.00 ± 1.29  *&† 198.28 ± 1.49  *&† 177.14 ± 1.34  *&†
PDT (n=30) 246.57 ± 4.92 * 219.14 ± 1.21 *&† 199.14 ± 2.19 *&† 178.28 ± 1.11*&†
N 60 20 20 20
Table 1- Mean ± Standard Deviation (SD) of body weight (g) in each group, treatment and period
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the examiner was trained by double measurements 
of 20 specimens, with a 1-week interval. Paired t-test 
statistics was run and no differences were observed 
"!& ,;(&#( !& + $0(%& =-)& <-#1 )"%-!& 51& + $0(& 6&
8@WS9@&A**","-! $$CD&J( )%-!X%&<-))($ ,"-!&<-(=><"(!,&
was obtained between the 2 measurements and 
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Statistical Analysis
The hypothesis that there were no differences 
in bone loss rate in the furcation region between 
treatment groups was tested using the Bioestat 
3.0 software (Bioestat, Windows 1995, Sonopress 
Brazilian Industry, Manaus, AM, Brazil). 
After the normality of radiographic data was 
analyzed by Shapiro-Wilk test, the intragroup and 
intergroup analysis was carried out with a two-way 
A3QZA&=-$$-'(*&?C&E0I(CX%&,(%,@&A&%"/!">< !<(&$(+($&
of 5% was set for all analysis. 
RESULTS
Clinical analysis
All non-dexamethasone animals (ND Group), 
Figure 1- !"#$ %"&& '($' )# *+$ ,$&)'% ($-)"# ". ,'#/)01%'( 2(&* ,"%'(3 456 78 -("19:;<=:>? /'@&A 4!6 8 -("19:;<=:>? 
days; (C) group ND/PDT/30 days; (D) D group/PDT/30 days. "MNO!"'(2#%$!(%*!M//)!N2(%%#%$P!NQFO!N>/)/*<%(.#'!F>,-(1<
Table 2- Mean ± Standard Deviation (SD) of the distance between the cementoenamel junction and the alveolar bone crest 
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    ND - non-dexamethasone (saline)
Groups
Periods 7 days 15 days 30 days
Treatments
SRP 1.12 ± 0.05 * & † 1.06 ± 0.03 * & 1.03 ± 0.07 * & †
PDT 0.80 ± 0.10 † 0.73 ± 0.03† 0.75 ± 0.07 †
N 20 20 20
D – dexamethasone
Groups
Periods 7 days 15 days 30 days
Treatments
SRP 1.40 ± 0.16 * & † 1.49 ± 0.29 * & † 1.50 ± 0.15 * & †
PDT 0.90 ± 0.02 † 0.87 ± 0.09 0.82 ± 0.06 †
N 20 20 20
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regardless of the treatment, presented no clinical 
differences in general health, and showed weight 
gain within the predicted range for healthy rats 
(Table 1). All dexamethasone-treated animals 
(D Group) presented progressive weight loss in 
 & %"/!">< !,& $(+($& ';(!& <-#1 )(*& ,-& ,;-%(& "!&
the ND group (Table 1), which show trends of 
immunosuppression and systemic alterations. 
Radiographic analysis
Intragroup radiographic assessment (ND and D) 
%;-'(*&,; ,&,;()(&' %&%"/!">< !,$C&$(%%&?-!(&$-%%&
in the animals treated with PDT in all experimental 
periods than in those treated with SRP (Figure 1, 
Table 2). Intergroup radiographic analysis (ND and 
D groups) demonstrated greater bone loss in the 
ND group treated with SRP compared that  the 
D group treated with PDT, at both 7- and 30-day 
periods (Figure 1, Table 2).
DISCUSSION
E;"%& %,0*C& <-#1 )(*& ,;(& "!G0(!<(& -=& J4E&  %&
an adjuvant treatment on induced periodontitis 
in dexamethasone-induced immunosuppressed 
rats. In the present study, the induced periodontal 
disease was characterized by clinical signs of 
/"!/"+ $& "!G ## ,"-!D& %0<;&  %& (*(# D& )(*!(%%&
and attachment loss of tooth gingival tissue. In 
the dexamethasone-inhibited animals (D group), 
,;(& <$"!"< $& %"/!%& -=& /"!/"+ $& "!G ## ,"-!&'()(&
more exacerbated, characterized as: a greater 
bone loss in the furcation region, connective tissue 
*"%-)/ !"P ,"-!D& *"%<)((,& >?)-?$ %,%&  !*& "!,(!%(&
"!G ## ,-)C&"!>$,) ,(&"!& $$&(R1()"#(!, $&1()"-*%D&
when compared to non-inhibited rats (ND).
The animals treated with this drug presented 
lethargy, hematoma and alopecia at the moment 
-=&% <)"><(@&[0),;()#-)(D& ,;()(&' %& &%"/!">< !,&
weight reduction throughout the present study. 
This fact probably occurred because the drug 
decreases gastrointestinal nutrient absorption11. 
These alterations have already been reported9, 
showing a trend towards immunosuppression and 
systemic alterations. 
The results of the present study have also 
demonstrated that the animals in the D group 
presented a greater bone loss in the furcation area, 
as well as more disorganized connective tissue 
when compared to the animals in the ND group. 
These alterations were described in another study 
that has also evaluated the corticoid effects upon 
periodontal tissues6.
On the other hand, a clinical study has not 
*(#-!%,) ,(*& "!G0(!<(& -=& <-),"<-%,()-"*& ,;() 1C&
on clinical parameters of periodontal disease in 
patients suffering from neurological disease13. The 
use of high doses of corticoid leads to a reduction 
of number and activity of osteoblasts, and an 
increase in the osteoclastic functions18. It also 
reduces gastrointestinal calcium absorption, which, 
in turn, results in lower blood calcium levels, and 
triggers PTH secretion that leads to systemic bone 
resorption23. However, another clinical study on 
liver transplant recipient has demonstrated that 
,;(& *-%(%& -=& /$0<-<-),"<-"*%& ; +(& !-,& "!G0(!<(*&
alveolar bone loss, although there was an inverse 
relationship with the duration of treatment13.  
Corticoids can lead to healing process delay by 
decreasing angiogenesis and capillary proliferation, 
';"<;& )(*0<(%& ?$--*& G-'14. They also interfere 
in phagocytosis and antigen digestion, inhibiting 
macrophage migrations and stabilizing lysosomes, 
avoiding proteolytic enzymes release. In addition, 
,;(C&#-*"=C& >?)-?$ %,& =0!<,"-!%D& *($ C"!/& ,;(")&
migration, damaging type-I and type-II pro-
collagen synthesis by modifying mRNA and mitotic 
activity17.
The number of studies investigating the PDT 
antimicrobial effects has increased. This therapy 
consists of the association of a photosensitizing 
agent with a light source, being initially used for 
oncology treatment27. Studies have shown favorable 
results using PDT principles against microorganisms 
involved in periodontitis29 and periimplantitis21.
The radiographic findings showed that the 
animals of the ND and D groups that received PDT 
,)( ,#(!,&1)(%(!,(*&$(%%&%"/!">< !,&?-!(&$-%%&,; !&
those treated with SRP alone, in all experimental 
periods. These results are in accordance with 
the literature, which has demonstrated PDT 
effectiveness in periodontal treatment for both 
animals2 and humans4. 
E;(&?(!(><" $&(==(<,&-=&J4E& %& !& *K0+ !,&#(,;-*&
to conventional mechanical treatment of periodontal 
disease, both in dexamethasone-inhibited and non-
inhibited rats, was probably caused by the photo-
destructive effects on the different ROS, mediated 
by type-I reaction (initiated by superoxide, anionic 
hydroxyl or free radicals) or by type-II reaction 
(initiated by singlet oxygen). These oxygen-reactive 
species are responsible for irreversible damage on 
bacterial cytoplasmic membrane, including protein 
#-*">< ,"-!D& )(%1") ,-)C& <; "!& ?)( I*-'!&  !*&
nucleic acid alterations27.
It was also evident in the present study that the 
animals in the D group that received PDT presented 
less bone loss when compared to those in the ND 
group that received SRP treatment alone, at both 
BH& !*&\8H* C&1()"-*%@&E;(&?(!(><" $&(==(<,%&-=&J4E&
in the periodontal disease could be explained not 
only by the local antimicrobial activity, previously 
described, but also by the increasing angiogenesis 
that brings more oxygenation to the area5.
Another possible explanation for the results 
obtained could be the biomodulation action of the 
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low-intensity laser alone. Studies have reported 
that the use of this source accelerates bone repair, 
1)(%(!,%& !,""!G ## ,-)C&(==(<,D&= +-)%&,;(&<($$0$ )&
chemotaxis8, and promotes local vasodilatation 
and angiogenesis25. Thus, it could increase oxygen 
diffusion through the tissue, favoring the repair 
1)-<(%%&?(< 0%(&<-$$ /(!&%(<)(,"-!&?C&>?)-?$ %,%&"!&
the extracellular space occurs only in the presence 
of high rates of oxygen pressure16.
Systemic corticoid use has been indicated in 
low and high doses for many treatments such as 
mucocutaneous and respiratory diseases, tendinitis, 
bursitis, arthritis and cysts in general3; it is also 
used in all levels of immunotherapy, based on the 
need and regimen prescribed by the individual 
practitioner26. One of the side effects of this drug is 
the increasing infection risk because of the inhibition 
effects of cellular immunity, which could cause more 
severe periodontal damages6, as demonstrated in 
this study.
Considering these facts, the application of 
alternative or adjuvant periodontal therapies to 
SRP conventional treatment, such as the use of 
systemic antibiotics, has been indicated, in spite 
of the disadvantage in developing bacterial drug 
resistance25,28. In this context, the use of local 
bactericidal agents would aid the periodontitis 
treatment.
The conventional periodontal treatment 
presents local limitations, such as effectiveness 
-=&#(<; !"< $& "!%,)0#(!, ,"-!& "!& *"=><0$,&  <<(%%&
areas, e.g., furcation region. PDT is not affected by 
this limitation as it is based on a photosensitizer 
agent associated with light emission, such as laser 
irradiation. Other advantages of PDT is having no 
side effect, initiating its activity only when exposed 
to a light source, and preventing from supporting 
resistant bacteria species selection9.
CONCLUSIONS 
Within the limitations of this study, it may be 
concluded that PDT was effective as a SRP adjuvant 
treatment for bone loss reduction in induced 
experimental periodontitis when compared to 
conventional nonsurgical treatment, both in normal 
rats and in systemic dexamethasone-inhibited 
animals.
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